These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 10922973)

  • 1. Lipids, protein intake, and diabetic nephropathy.
    Gin H; Rigalleau V; Aparicio M
    Diabetes Metab; 2000 Jul; 26 Suppl 4():45-53. PubMed ID: 10922973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beneficiary effect of dietary soy protein on lowering plasma levels of lipid and improving kidney function in type II diabetes with nephropathy.
    Azadbakht L; Shakerhosseini R; Atabak S; Jamshidian M; Mehrabi Y; Esmaill-Zadeh A
    Eur J Clin Nutr; 2003 Oct; 57(10):1292-4. PubMed ID: 14506491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reducing protein in the diabetic diet.
    Pedersen MM; Winther E; Mogensen CE
    Diabete Metab; 1990; 16(5):454-9. PubMed ID: 2073971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diabetic nephropathy and prevention of diabetic nephropathy caused chronic renal insufficiency].
    Jakić M; Jakić M; Zibar L; Mihaljević D; Stipanić S; Teskera T
    Lijec Vjesn; 2009; 131(7-8):218-25. PubMed ID: 19769285
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adequate protein dietary restriction in diabetic and nondiabetic patients with chronic renal failure.
    Meloni C; Tatangelo P; Cipriani S; Rossi V; Suraci C; Tozzo C; Rossini B; Cecilia A; Di Franco D; Straccialano E; Casciani CU
    J Ren Nutr; 2004 Oct; 14(4):208-13. PubMed ID: 15483780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Place of dietary protein restriction in the treatment of diabetic nephropathy].
    Aparicio M
    Nephrol Ther; 2006 Jan; 2 Suppl 1():S32-8. PubMed ID: 17378138
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of tumor necrosis factor-alpha in insulin sensitivity and effect of low protein diet on the TNF-alpha response in patients with diabetic renal failure].
    Nishimura M; Hatakeyama E; Wakabayashi Y; Nakano H; Suzuki S; Miura Y; Tsuchida H; Yamada K
    Nihon Jinzo Gakkai Shi; 1997 Oct; 39(7):740-5. PubMed ID: 9396242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kidney involvement and disease in patients with diabetes.
    Chiarelli F; Trotta D; Verrotti A; Mohn A
    Panminerva Med; 2003 Mar; 45(1):23-41. PubMed ID: 12682618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Farnesoid X receptor modulates renal lipid metabolism, fibrosis, and diabetic nephropathy.
    Jiang T; Wang XX; Scherzer P; Wilson P; Tallman J; Takahashi H; Li J; Iwahashi M; Sutherland E; Arend L; Levi M
    Diabetes; 2007 Oct; 56(10):2485-93. PubMed ID: 17660268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of weight loss using formula diet on renal function in obese patients with diabetic nephropathy.
    Saiki A; Nagayama D; Ohhira M; Endoh K; Ohtsuka M; Koide N; Oyama T; Miyashita Y; Shirai K
    Int J Obes (Lond); 2005 Sep; 29(9):1115-20. PubMed ID: 15925953
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soy protein intake, cardiorenal indices, and C-reactive protein in type 2 diabetes with nephropathy: a longitudinal randomized clinical trial.
    Azadbakht L; Atabak S; Esmaillzadeh A
    Diabetes Care; 2008 Apr; 31(4):648-54. PubMed ID: 18184902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complete remission of diabetic nephropathy in a type 1 diabetic patient with near-nephrotic range proteinuria and reduced renal function.
    Haraguchi K; Hara S; Ubara Y; Tanaka S; Nukui I; Shimura H; Ohashi K; Kobayashi T
    Diabetes Res Clin Pract; 2009 Mar; 83(3):295-9. PubMed ID: 19162360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential influence of lipids in diabetic nephropathy: insights from experimental data and clinical studies.
    Bonnet F; Cooper ME
    Diabetes Metab; 2000 Sep; 26(4):254-64. PubMed ID: 11011217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of an oral adsorbent on renal function in chronic renal failure: determinants of its efficacy in diabetic nephropathy.
    Sanaka T; Akizawa T; Koide K; Koshikawa S
    Ther Apher Dial; 2004 Jun; 8(3):232-40. PubMed ID: 15154877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in metabolic disorders: hypercholesterolaemia and diabetes].
    Strawn WB
    Drugs; 2002; 62 Spec No 1():31-41. PubMed ID: 12036387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of soy protein consumption for renal function.
    Anderson JW
    Asia Pac J Clin Nutr; 2008; 17 Suppl 1():324-8. PubMed ID: 18296369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic nephropathy.
    Ritz E
    Saudi J Kidney Dis Transpl; 2006 Dec; 17(4):481-90. PubMed ID: 17186681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic effects of oral contraceptive steroids on biochemical markers for arterial thrombosis. Studies in non-diabetic women and in women with insulin-dependent diabetes mellitus.
    Petersen KR
    Dan Med Bull; 2002 Feb; 49(1):43-60. PubMed ID: 11894723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of microvascular and macrovascular complications in diabetes mellitus.
    Maji D
    J Indian Med Assoc; 2004 Aug; 102(8):426, 428, 430 passim. PubMed ID: 15719805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.